CGM SKD vs Importing a Finished CGM: Duty, Tenders and Margin
2026-10-26 · Verid Bio
Every organisation entering the CGM market eventually asks the same question: should we import a finished device, or build local production through SKD? The two paths look similar on the surface — both get you a CGM to sell — but they differ in duty treatment, tender eligibility, registration ownership and margin in ways that compound year after year. (New to SKD? Start with what CGM SKD means.)
This guide puts CGM SKD and finished-device import side by side on the dimensions that actually decide the question for a business.
The core difference in one sentence
With a finished import, the device is complete and certified when it arrives — and the manufacturer keeps the approval. With SKD, the device is finished locally — and your organisation holds the registration.
Everything else follows from that single difference.
Side-by-side comparison
| Dimension | Finished-device import | CGM SKD |
|---|---|---|
| What arrives | A complete, certified CGM | Tested, calibrated core components |
| Who finishes the device | Nobody — it ships done | Your team, with SOPs and training |
| Registration holder | The foreign manufacturer | Your organisation |
| Duty treatment | Finished medical device rate | Often component rate, lower |
| Local-content / tender eligibility | Generally unavailable | Available |
| Brand & lifecycle control | Packaging only | Packaging, manual, language, app |
| Capability required | Distribution and marketing | Cleanroom, quality system, trained staff |
| Time to market | Fastest | Fast once enablement is scheduled |
When finished-device import is the right call
Import is not the wrong answer — it is the right answer in specific situations:
- You are testing demand. Before committing to local production, an imported device lets you validate the market with the lowest set-up cost.
- Speed is everything. When a programme or a launch window matters more than unit economics.
- The device is a complement, not the core. When the CGM sits alongside a business you already run, and local registration is not the point.
The trade-off is structural: you keep the lowest setup, but you also keep the highest landed cost and none of the local-production advantages.
When SKD wins
SKD earns its set-up cost back where the numbers and the strategy matter:
- Your market rewards local production. If tenders, duty or local-content rules favour locally manufactured devices, import disadvantages you structurally.
- You want to own the market access. A registration in your own name is an asset that survives a supplier change.
- You have a real channel. Pharmacy networks, hospital procurement or distributor reach — SKD compounds an existing route to patients.
- You plan to be in this market for years. The structural margin advantage of SKD compounds the longer you run.
The margin math, simply
The comparison that matters is total landed cost, not sticker price. SKD changes three numbers at once:
- Duty. Components are commonly treated differently from a finished medical device.
- Margin. The assembly and distribution margin you would pass upstream stays in your business.
- Access. Local-content and tender eligibility open revenue that an import cannot reach.
Against that, import's advantage is speed and low set-up — which is real, but one-time.
A practical sequencing path
The two models are not an either-or forever. A common and sensible pattern is:
Import (or distribute) to learn the market → SKD to gain local origin, registration and margin → CKD where scale justifies full localisation.
Choosing the model you can execute this year, with a clear option on the next step, beats committing to the model you would ideally hold in five.
Frequently asked questions
Is SKD always cheaper than importing a finished CGM? On total landed cost, usually yes once duty, tender eligibility and the retained margin are counted — but it requires a set-up and capability investment that import does not.
Which is faster to market? Finished import. SKD is fast once enablement is scheduled because the long-lead sensor engineering is already done, but it is not the zero-set-up path import is.
Do I need manufacturing experience for SKD? No — assembly is guided snap-fit work with training and SOPs. Basic cleanroom protocol knowledge is enough to start; what you need is a route to market.
Can I switch from import to SKD later? Yes, and many organisations do exactly that — import to validate demand, then SKD to gain origin and margin once the market is proven.
Deciding between CGM SKD and finished import? Talk to our team → and we will model both against your market.